Precautions for Ivesumumab: Avoid the occurrence of allergic reactions
Evinacumab is an innovative drug for the treatment of homozygous familial hypercholesterolemia (HoFH). Although it brings significant therapeutic effects to patients, during use, great attention must be paid to possible allergic reactions, and effective measures must be taken for prevention and treatment.
Ivesumumab may cause a serious allergic reaction, including swelling (especially of the lips, tongue, or throat, making it difficult to swallow or breathe), difficulty breathing or wheezing, and hives. These reactions can be life-threatening and patients should be fully informed of this risk before using everevuximab.
Before using everuximab for the first time, patients should inform their doctor in detail about their allergic history, especially allergies to drugs, foods, or other substances. Its use should be contraindicated if the patient has an allergic reaction to evesumumab or similar drugs.
Before starting evesumumab treatment, doctors should conduct a comprehensive assessment of the patient, including liver and kidney function, allergy history, family medical history, etc. This helps doctors determine whether the patient is suitable for using evisumumab and formulate a corresponding medication plan.
During the use of everuximab, patients should closely monitor their physical condition, especially injection site reactions and symptoms of systemic allergic reactions. If any discomfort occurs or an allergic reaction is suspected, stop taking the medication immediately and inform your doctor.
If an allergic reaction occurs while using everevuximab, patients should seek medical attention immediately. Doctors will take appropriate treatment measures based on the patient's symptoms, such as using anti-allergic drugs, inhaling oxygen, and maintaining stable vital signs. In severe cases, emergency treatment may be required.
Patients should strictly follow their doctor's recommendations and prescriptions when using everevuximab, including dosage, frequency and method of administration. Do not adjust the dosage or change the medication method by yourself to avoid affecting the efficacy or increasing the risk of adverse reactions.
Reference materials:https://www.drugs.com/mtm/evinacumab.html
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)